Comparison

CB 300919 European Partner

Item no. TMO-T14879-200mg
Manufacturer TargetMol
CASRN 289715-28-2
Amount 200 mg
Quantity options 100 mg 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 25 mg 50 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C32H34ClN7O2
Smiles CN1CCN(Cc2nc3cc(Cl)c(CN(CC#C)c4ccc(cc4)C(=O)NCc4cccnc4)cc3c(=O)n2C)CC1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others|||NAMPT
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
584, 11
Description
CB 300919 is a quinazoline-based antitumor agent exhibiting high activity against CH1 human ovarian tumor xenografts, with continuous exposure (96 h) resulting in a growth inhibition (IC50: 2 nM).
Pathways
Metabolism|||Others
Bioactivity
CB 300919 is a quinazoline-based antitumor agent with high activity in the CH1 human ovarian tumor xenograft and has continuous exposure (96 h) growth inhibition (IC50: 2 nM).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close